DLBDolby Laboratories, Inc.
Is it growing?
Growth is fading: earnings down −14% year on year and operating margin narrowing (−3.6 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +1% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.
Trailing-twelve-month operating margin, 16.8% now against 20.5% a year earlier.
All from SEC EDGAR, as of Jun 26, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is DLB growing?
Dolby Laboratories, Inc.'s revenue has grown 1.7% a year over three years, and grown 1.3% a year over five, with earnings per share compounding at 1.3%.
Revenue growth, 3-year annual rate · Specialty Business Services median +8.8% · growing slowly · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +1.3%
Revenue growth, 5-year rate · +1.7% over three · growth has picked up over the last three years
- Earnings per share, 3-year rate
- +1.3%
Earnings per share, 3-year rate · revenue +1.7% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 18
Years of annual history on file · FY2008 to FY2025, as filed
Details›
- Revenue FY2021
- $1.28B
- Revenue FY2022
- $1.25B
- Revenue FY2023
- $1.30B
- Revenue FY2024
- $1.27B
- Revenue FY2025
- $1.35B
Annual income statements as filed with the SEC.
Specialty Business Services
Ranks #8 of 21 by RyuScore